Cargando…
Dexmedetomidine for Sedation during Withdrawal of Support
Agents used to control end-of-life suffering are associated with troublesome side effects. The use of dexmedetomidine for sedation during withdrawal of support in pediatrics is not yet described. An adolescent female with progressive and irreversible pulmonary deterioration was admitted. Despite wee...
Autores principales: | O’Hara, Chris, Tamburro, Robert F, Ceneviva, Gary D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551302/ https://www.ncbi.nlm.nih.gov/pubmed/26339188 http://dx.doi.org/10.4137/PCRT.S27954 |
Ejemplares similares
-
Dexmedetomidine Withdrawal Mimicking ST-Elevation Myocardial Infarction
por: Lakra, Pallavi, et al.
Publicado: (2023) -
Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023) -
Changes in brain activation during sedation induced by dexmedetomidine
por: Kim, Won-Ho, et al.
Publicado: (2017) -
Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult
por: Jung, Jae Wook, et al.
Publicado: (2013) -
Dexmedetomidine intravenous sedation using a patient-controlled sedation infusion pump: a case report
por: Chi, Seong In, et al.
Publicado: (2016)